Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Considering that the copper-associated mitochondrial toxicity may have been delayed, we further explored the changes in the expression of skin irritation-related biomarkers at the genomic level
Physiologia , 4 , 433444
Viking Therapeutics (VKTX) Stock price: $52.74 TTM EPS: ($0.92) EPS growth: (2.13%) Dividend yield: NA Business Overview Viking Therapeutics develops treatments for metabolic and endocrine disorders
T2D=type 2 diabetes
The AI system automatically identified and organized key study attributes (e.g., design, sample size, outcomes) and flagged sections relevant to renal endpoints and risk-of-bias domains
US$ 21.20
US$ 24.58
US$ 21.27
